A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Besides the NIH? I mean, technically, the work that we did with MERS, where we were given a waiver, as far as I know it was never really reviewed for GOF. It decided that it was in the national interest to develop a mouse model so that countermeasures could be developed against MERS. The virus has a 35 percent mortality rate. It could transmit to people, and it could transmit through asymptomatic spread. So there's a threat potential there. I think NIH made the right call in that case, that you develop the appropriate reagents so that you can move countermeasures forward to protect the public.
-
Okay. So have you ever done gain-of22 function research under any other federally funded grant?
-
No.
-
Have you ever, you know, created a virus or provided sequences or done something under a contract DC.Scheduling@LexitasLegal.com where you were not the one that was actually conducting gain-of-function research, but the overarching experimental research was --
-
2026-04-10 09:00
Ralph S. Baric
Can you put that into a direct example, rather than this global thing that requires me to remember everything that I did in the last 40 years of my life?
-
The only gain-of-function that you have ever done or been involved in is the one that you received an exemption for.
-
Every gain-of-function? Once the pause occurred, anything that we did that had potential for gain12 of-function was reviewed by the NIH, yes.
-
I mean, so you only did that kind of work for NIH.
-
Yes.